TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -66.7% | 78 | -58.1% | 0.00% | -100.0% |
| Q2 2023 | $3 | 0.0% | 186 | -9.7% | 0.00% | 0.0% |
| Q1 2023 | $3 | -57.1% | 206 | -54.2% | 0.00% | 0.0% |
| Q4 2022 | $7 | -99.9% | 450 | -44.6% | 0.00% | -66.7% |
| Q3 2022 | $11,000 | +1000.0% | 813 | +783.7% | 0.00% | – |
| Q2 2022 | $1,000 | -92.3% | 92 | -88.5% | 0.00% | -100.0% |
| Q3 2021 | $13,000 | – | 797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |